U.S. Machinery Stock News

Upstart Holdings has seen its share price come under heavy pressure in recent years, and that slide puts a spotlight on a simple question for you as an investor. Is the current valuation of Upstart stock still supported by what the business is earning today and what those earnings suggest it could deliver over time. Over the past 5 years, the share price has fallen about 92.4%, which puts a lot of weight on whether the remaining market value lines up with the company’s earnings power. The...

Universal (UVV) drew fresh attention after terminating J. Patrick O’Keefe, Vice President of Ingredients, without cause on September 15, 2026, while continuing its previously announced search for his successor. Universal’s share price has eased in recent months, with the stock down 14.3% over 90 days and 16.1% year to date at US$44.14. Longer term total shareholder returns of 11.2% over three years and 25.9% over five years point to a more resilient history despite recent weakness. Capitalize...

W. P. Carey has delivered solid long term gains for holders, even as more recent trading has been choppy. That puts a spotlight on whether the earnings behind the stock now justify the current price. With real estate investors also watching fresh company updates, the question is how much of the underlying profit story is already reflected in that US$66.26 closing level. Over the past 3 years the stock has returned 40.2%, which raises the stakes on whether the current earnings profile can...

Berkshire Hathaway (BRK.A) moved back into the spotlight after Warren Buffett stepped down as chairman and became Chairman Emeritus, with long-time director Howard Buffett taking over the board role. Recent boardroom headlines have arrived while Berkshire Hathaway’s 1 month share price return of 2.70% and 3 month share price return of 3.98% point to steady, if measured, momentum, with a 1 year total shareholder return of 3.13% and a 5 year total shareholder return of 82.64% reminding...

Mattel announced a new Thomas & Friends animated special, Really Helpful Engines, along with a refreshed Railway Stories series and reimagined global toy line, plus a separate multi-year licensing deal bringing Bluey into Barbie, Hot Wheels, Fisher-Price, Polly Pocket and UNO products. The twin push into fresh Thomas content tied directly to a redesigned Easy Connect track system and a broad Bluey licensing rollout deepens Mattel’s use of owned and partner IP across both streaming and...

Artisan Partners Asset Management has faced pressure from sluggish 2.8% annualized revenue growth, a 1.3% annual decline in EPS, and a recent month-on-month drop in assets under management. The combination of softer long term fundamentals and fresh AUM weakness points to business headwinds that go beyond short term market noise. The focus now turns to how this weaker earnings and assets under management profile could reshape Artisan Partners Asset Management's investment narrative. Balance...

Marzetti (MZTI) came back into focus after fresh commentary highlighted its slower annual revenue expansion versus other consumer staples peers and a forward P/E of 15.3x. This has prompted investors to reassess what they are paying for this business. Marzetti’s recent share price slide, with a 30 day share price return down 10.49% and year to date share price return down 39.28%, points to fading momentum as investors weigh slower revenue expansion against that 15.3x forward P/E. The 1 year...

Viasat (VSAT) has just completed a major step in its satellite roadmap, with the ViaSat-3 F2 satellite entering service across the Americas and the Equatys joint platform with Space42 moving forward for global direct-to-device connectivity. The recent ViaSat-3 milestone and Equatys partnership arrive during a period of strong investor interest in Viasat, with the share price at $76.38 after a 1-day share price return of 4.60% and a year-to-date share price return of 102.98%. The 1-year total...

Washington now talks about an “AI tsar” and an “AI Force,” and that kind of political spotlight can reshape where capital and talent flow next. A looser regulatory tone around AI, cloud and data infrastructure may change how investors think about risk and reward across the sector. This article walks through three US AI and data infrastructure stocks that are exposed to that policy shift, and explains why their stories matter for your portfolio decisions. The three stocks below are just a...

AI policy has moved from think-tank white papers to the campaign stage, with Donald Trump promising to push hard for growth, new federal firepower and an “AI Force” while keeping tight regulation at bay. That kind of political tailwind can reshape where government technology dollars flow, and fast. This article explains how that backdrop touches three US AI focused government IT and defense contractors, and why their exposure to this news matters for your watchlist. The stocks highlighted...

Aptiv (APTV) has been under pressure, with the share price around $43.59 and trailing returns weaker over the past year and the past 3 months. That recent performance frames the current investment debate. Aptiv’s recent slump has been steady rather than sudden, with the share price return down 10.9% over the past month and 31.6% over 90 days, while the 1 year total shareholder return has declined 39.7%. This points to fading momentum as investors reassess growth prospects and risk. Scan...

MillerKnoll has seen its share price move around over the years, and the current US$20.66 level puts a fresh spotlight on what investors are really paying for its earnings power. With the stock showing mixed returns across different time frames, the question now is how well the current P/E lines up with the profitability of the business. The share price declined 40.5% over the past 5 years, which puts extra weight on whether the earnings story today supports a different outcome over the next...

Surgery Partners (SGRY) updated its 2026 outlook, guiding revenue to a range of $3.08b to $3.18b. The revision reflects the removal of Idaho Falls Facilities’ contribution for the rest of the year. The updated 2026 outlook lands as Surgery Partners’ share price has been under pressure, with the stock down 7.86% over the past week and 13.17% year to date on a share price return basis, while the 1-year total shareholder return has declined 38.71%. This points to fading momentum as investors...

Advance Auto Parts recently opened a new store and market hub in Woodbridge, New Jersey, as part of a broader supply chain overhaul that consolidates its distribution footprint from 38 centers to 12 by 2026. This tighter network is designed to cut logistics costs and sharpen in-stock availability, which affects the core economics of how Advance Auto Parts serves professional and retail customers. We will now explore how this consolidation of 38 distribution centers into 12 could reshape...

Interparfums (IPAR) extended its exclusive global license for Roberto Cavalli and Just Cavalli fragrances by 20 years to December 31, 2046, providing investors with a clearer view of long-term brand access. Recent price action suggests steady interest in Interparfums, with the 1 day share price return of 1.60% and 90 day share price return of 13.54% sitting alongside a 1 year total shareholder return of 14.71% and 5 year total shareholder return of 78.61%. This indicates momentum that has...

AerCap Holdings announced that its board authorized a share repurchase program on 16 September 2026, allowing the company to buy back up to US$1.0b of its stock through 30 June 2027. The program will be funded by cash on hand and cash generated from operations. The new buyback plan indicates that AerCap Holdings is comfortable using ongoing operating cash flows for capital returns. This is relevant for investors who are weighing future balance sheet flexibility against potential benefits...

Carter's new collection and what it might mean for the stock Carter's (CRI) is rolling out its Not-So-Scary Monsters sleepwear and playwear line, pairing character driven bedtime routines with an in app Monster Room Scanner, giving investors a fresh product story to watch. Recent trading has been rough for Carter's, with the share price at about $29.64 after a 30 day share price return that declined 20.3% and a 90 day share price return that fell 30.3%. The 1 year total shareholder return is...

Green Brick Partners and HFI Capital Management recently marked a key milestone at the Rainwater Crossing master-planned community in Celina, Texas with the opening of Whispering Grove, a two-acre entrance park that anchors a planned 1,800-home development featuring extensive parks, trails, and future amenity centers. The combination of visible progress at Rainwater Crossing and CEO Jim Brickman’s comments on capital strength and potential builder acquisitions provides investors with more...

Incyte reported that MINJUVI, a humanized anti CD19 antibody used with rituximab and lenalidomide for relapsed or refractory follicular lymphoma, is now funded in Ontario through the FAST Program. This gives eligible patients earlier access while reimbursement discussions continue. This Ontario FAST listing for MINJUVI highlights how payer decisions can shape real world demand patterns and operating visibility for Incyte’s broader oncology portfolio. We will now examine how Incyte's...

Greif, Inc. has exited the coated recycled paperboard market after shutting its Sweetwater mill in Austell, Georgia. This removes roughly 120,000 tons of annual capacity and affects around 90 employees, who are receiving severance and career support. The Sweetwater closure highlights Greif’s push to concentrate capital on operations with stronger competitive positions and better integration across its North American paperboard network. We will now examine how Greif’s decision to close the...

Maze Therapeutics (MAZE) has drawn investor attention after a weak run for the shares, with the price down 24% over the past month and 12% over the past 3 months. That short-term weakness sits against a tougher backdrop for Maze Therapeutics, with the year-to-date share price return down 43.37% even though the 1-year total shareholder return is only 1.83% lower. Momentum has clearly faded, and recent moves suggest investors are reassessing both growth potential and clinical or funding risks...

Why Teladoc Health’s latest earnings matter for investors Teladoc Health (TDOC) set the tone for the stock this week after reporting quarterly results that showed a 4% revenue decline, missed forecasts on profitability, and softer guidance for the coming quarter. The update pointed to a 9.2% average drop in customer spending in recent years even as user counts grew. Management signaled expectations for another period of lower revenue and negative earnings per share. Recent trading suggests...

Bond markets have stolen the spotlight in 2026, with surging government yields, pricier mortgages and renewed inflation worries shaking assumptions about what different stocks are really worth. That stress creates an opportunity for investors who understand how trading platforms and custody firms can be affected when cash becomes more valuable and bond markets swing harder. This article walks through three stocks exposed to this story and explains how the recent move in yields could matter...

Ituran Location and Control reported record Q2 2026 revenue of US$104.8 million, with recurring subscription income and total subscribers both higher. The Israeli Ministry of Transport also awarded the business a multi year SaaS traffic monitoring contract worth over NIS 21 million. The new agreement for a nationwide Big Data traffic platform signals that Ituran Location and Control’s proprietary analytics are being adopted for core public infrastructure decisions, extending the telematics...